Cengild Medical Berhad Q1 2024 Revenue 11% Growth vs Preceding Quarter.
Cengild Medical Berhad Q1 2024 concluding on September 30, 2023, achieved a revenue of RM17.60 million. This marks a notable growth of RM1.83 million, equivalent to 11.62%, when juxtaposed with the preceding quarter concluding on June 30, 2023, which reported revenue of RM15.77 million.
